Incyte Corporation (INCY) News Headlines

▮ More

Date

Headline

7/30/2019 7:31:55 AM Incyte Corporation Q2 adjusted earnings Beat Estimates

7/30/2019 7:06:21 AM Incyte Q2 EPS $0.48 Vs $0.24 Last Year

7/30/2019 7:01:22 AM Incyte Q2 19 Earnings Conference Call At 8:00 AM ET

7/2/2019 7:35:18 AM Incyte And Zai Lab Announce Collaboration And License Agreement For INCMGA0012 In Greater China

6/15/2019 10:37:45 AM Incyte Announces Positive Results From Phase 2 Study Of Ruxolitinib Cream In Patients With Vitiligo

6/4/2019 7:32:53 AM Incyte Says First Patient Treated In FIGHT-302 Phase 3 Study

4/30/2019 8:07:16 AM Incyte To No Longer Participate In Co-funding Of Development Of Baricitinib

4/30/2019 7:18:52 AM Incyte Corporation Q1 adjusted earnings of $0.62 per share

4/30/2019 7:07:06 AM Incyte Q1 EPS $0.47; Non-GAAP EPS $0.62

4/26/2019 3:15:22 AM Biotech Stocks Facing FDA Decision In May 2019

2/21/2019 5:54:23 AM Beware Of Fake Leukemia Drug Iclusig, Warns WHO

2/14/2019 7:03:28 AM Incyte Q4 EPS $0.32 Vs Loss $0.71 Last Year

2/7/2019 7:06:28 AM Incyte Says FDA Extended Review Period For Ruxolitinib In Acute Graft-Versus-Host Disease

2/4/2019 6:52:11 AM Lilly : Baricitinib Meets Primary Endpoint In BREEZE-AD1 And BREEZE-AD2

2/4/2019 6:46:28 AM Lilly Says Baricitinib Meet Primary Endpoint In BREEZE-AD1 And BREEZE-AD2 Phase 3 Studies

1/30/2019 2:19:45 AM Biotech Stocks Facing FDA Decision In February

1/22/2019 7:30:21 AM Incyte Announces First Patient Treated In Phase 3 Clinical Trial Of Itacitinib For Chronic Graft-Versus-Host Disease

1/7/2019 7:03:34 AM Merus Says FDA Accepted IND Application For MCLA-145

1/3/2019 10:02:08 AM Incyte To Present At Goldman Sachs Conference; Webcast At 11:00 AM ET

1/3/2019 7:08:45 AM Incyte Names Christiana Stamoulis CFO - Quick Facts